On November 19, 2026, the U.S. Department of Health and Human Services (“HHS”) published a final rule making several changes to the HIPAA Privacy Rule intended to facilitate individuals’ access to protected health information (“PHI”) and care coordination. The final rule adopts many of the changes HHS proposed in January 2021 and also appears to address the access-timing changes that HHS had signaled in the 2026 Unified Agenda it would pursue in a separate proposed rule.

Among other changes, the final rule shortens the timeframe for responding to access requests, addresses individuals’ access to electronic PHI through personal health applications, modifies the content requirements of a covered entity’s Notice of Privacy Practices (“NPP”), and clarifies certain permitted disclosures for care coordination and case management purposes. The final rule is effective January 19, 2027, and regulated entities must comply with the applicable requirements by July 19, 2027.

Some of the key changes in the final rule include:

  • Individual Access to PHI. The final rule requires covered entities to respond to an individual’s request to access PHI as soon as practicable, but no later than 15 calendar days after receiving the request, a reduction from the current timeframe of 30 calendar days. Where another federal or state law requires a covered entity to provide access in less than 15 calendar days, the final rule treats that shorter timeframe as practicable for purposes of the HIPAA right of access. Covered entities may extend the access request deadline once by no more than 30 additional calendar days if they notify the individual in writing within the initial 15-day period of the reason for the delay and the date by which they will complete the request. The final rule also clarifies that an individual’s right to direct a covered entity to transmit PHI to a designated person is limited to electronic copies of PHI in an electronic health record, to the extent the PHI constitutes a designated record set. Additionally, the final rule prohibits covered entities from imposing unreasonable verification requirements that impede individuals from exercising their access rights when less burdensome measures are practicable.
  • Personal Health Applications and Electronic Access. The final rule creates a new definition of a “personal health application,” which is an electronic application used by an individual to access health information about that individual where the information is managed, shared, and controlled by or primarily for the individual, rather than by or primarily for a covered entity or another person. When an individual requests access to PHI through a personal health application, the final rule treats access through the application as access by the individual directly, rather than as a request for disclosure to a third party. If the requested PHI is readily producible through the application, the covered entity must provide the PHI in that manner. The final rule does not, however, independently require covered entities to implement new technologies to provide access through personal health applications. HHS also clarifies that an app developer does not become a business associate merely because an individual uses its personal health application to access PHI, although the same developer may nevertheless be a business associate with respect to a different product or service that it provides for or on behalf of a covered entity or business associate. Covered entities generally may not deny access through such applications based on concerns about the application’s privacy practices or impose unreasonable or unnecessary barriers to an application’s registration with an available API, including solely because the developer lacks a business associate agreement or offers competing services.
  • Notice of Privacy Practices. The final rule requires covered entities to revise their NPPs in several respects, including to describe how individuals can exercise their right to obtain copies of their PHI at limited cost or, in some cases, free of charge, and their right to direct electronic copies of certain PHI to another person. The rule also requires NPPs to state that individuals have a right to discuss the notice with a designated contact person or office, and to provide a telephone number and email address for that contact. In addition, covered entities must revise the standardized NPP header to highlight individuals’ access and complaint rights and their right to receive a copy of and discuss the NPP. The final rule separately eliminates the requirement that covered health care providers with direct treatment relationships make a good-faith effort to obtain written acknowledgment that an individual received the provider’s NPP.
  • Access Fees and Fee Transparency. The final rule prohibits covered entities from charging fees for inspecting PHI or accessing electronic PHI through an automated internet-based method. Where a covered entity charges fees for copies of PHI, the final rule also requires the entity to post an estimated fee schedule on its website and make the schedule available at the point of service and upon request.
  • Care Coordination and Case Management. The final rule clarifies that “health care operations” includes both individual-level and population-based care coordination and case management activities. It also expressly permits covered entities to disclose PHI without an individual’s authorization to social services agencies, community-based organizations, home- and community-based services providers, and similar third parties that provide health-related services to the individual, for individual-level care coordination and case management that constitute treatment or health care operations. HHS did not, however, finalize its proposal to create an exception to the HIPAA minimum necessary standard for individual-level care coordination and case management. Accordingly, the minimum necessary requirements continue to apply to these disclosures where otherwise applicable.
  • Business Associate Agreements (“BAAs”). The final rule clarifies how covered entities and business associates may allocate responsibility for responding to individual access requests. BAAs may specify whether the business associate will provide requested PHI directly to the individual or instead provide the PHI to the covered entity for the covered entity to respond to the request. The final rule provides an extended transition period for amending certain existing BAAs to reflect the new requirements (e.g., with respect to the timing for complying with access requests). Qualifying BAAs are deemed compliant until the earlier of (1) the date on which the agreement is renewed or modified on or after the general compliance date or (2) January 18, 2028. Covered entities and business associates must nevertheless comply with the final rule’s substantive requirements beginning on the applicable compliance date.

Other changes to the Privacy Rule include requiring covered entities that are, or provide services to, correctional institutions to provide NPPs to individuals who are inmates; permitting certain disclosures of PHI to Telecommunications Relay Services (“TRS”) communications assistants and excluding TRS providers from the definition of “business associate”; and expanding the permission to use or disclose PHI of Armed Forces members in certain circumstances to all Uniformed Services, including the U.S. Public Health Service Commissioned Corps and the National Oceanic and Atmospheric Administration Commissioned Corps.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Libbie Canter Libbie Canter

Libbie Canter represents a wide variety of multinational companies on managing privacy, cyber security, and artificial intelligence risks, including helping clients with their most complex privacy challenges and the development of governance frameworks and processes to comply with U.S. and global privacy laws.

Libbie Canter represents a wide variety of multinational companies on managing privacy, cyber security, and artificial intelligence risks, including helping clients with their most complex privacy challenges and the development of governance frameworks and processes to comply with U.S. and global privacy laws. She routinely supports clients on their efforts to launch new products and services involving emerging technologies, and she has assisted dozens of clients with their efforts to prepare for and comply with federal and state laws, including the California Consumer Privacy Act, the Colorado AI Act, and other state laws. As part of her practice, she also regularly represents clients in strategic transactions involving personal data, cybersecurity, and artificial intelligence risk and represents clients in enforcement and litigation postures.

Libbie represents clients across industries, but she also has deep expertise in advising clients in highly-regulated sectors, including financial services and digital health companies. She counsels these companies — and their technology and advertising partners — on how to address legacy regulatory issues and the cutting edge issues that have emerged with industry innovations and data collaborations.

Chambers USA 2026 ranks Libbie in Band 2 Nationwide for both Privacy & Data Security: Privacy and Privacy & Data Security: Healthcare.Chambers USA notes, Libbie is “incredibly sharp and really thorough. She can do the nitty-gritty, in-the-weeds legal work incredibly well but she also can think of a bigger-picture business context and help to think through practical solutions.”

Photo of Elizabeth Brim Elizabeth Brim

Elizabeth Brim provides strategic advice to clients across the health care, life sciences, digital health, and technology sectors, helping them navigate complex privacy, regulatory, and compliance issues involving health and other personal information.

Elizabeth advises clients on compliance with evolving privacy, data governance…

Elizabeth Brim provides strategic advice to clients across the health care, life sciences, digital health, and technology sectors, helping them navigate complex privacy, regulatory, and compliance issues involving health and other personal information.

Elizabeth advises clients on compliance with evolving privacy, data governance, and regulatory frameworks governing the collection, use, disclosure, and protection of health, genetic, consumer health, and other sensitive data. Her work includes counseling on HIPAA, state privacy laws, information blocking requirements, TEFCA, and other federal and state laws affecting health information, digital health technologies, and privacy compliance more broadly.

Elizabeth’s experience spans a broad range of privacy, data governance, cybersecurity, and regulatory issues arising in connection with innovative products and services, artificial intelligence and other emerging technologies, clinical trials and research initiatives, strategic transactions, and commercial arrangements. She regularly advises clients on complex issues involving data governance, privacy compliance, and the protection and exchange of health and other sensitive information.

Elizabeth also advises clients on related health care regulatory and compliance matters, including fraud and abuse, corporate practice of medicine, and other requirements affecting innovative care delivery models.

Elizabeth maintains an active pro bono practice, which includes assisting nonprofit entities with data privacy compliance and vendor contracting.

Elizabeth is an author of the American Health Law Association treatise, Pricing, Market Access, and Reimbursement Principles: Drugs, Biologicals and Medical Devices and the U.S. chapter of the Global Legal Insights treatise, Pricing & Reimbursement Laws and Regulations.

Photo of Kyle Falkner Kyle Falkner

Kyle Falkner is an associate in the firm’s Washington, DC office. He is a member of the Data Privacy and Cybersecurity Practice Group and the Health Care Practice Group.

Kyle advises clients on a wide range of data privacy, technology, and health care…

Kyle Falkner is an associate in the firm’s Washington, DC office. He is a member of the Data Privacy and Cybersecurity Practice Group and the Health Care Practice Group.

Kyle advises clients on a wide range of data privacy, technology, and health care issues. He assists clients in complying with U.S. state and federal privacy laws as well as federal health care laws and regulations.

Kyle also maintains an active pro bono practice focused on supporting international human rights initiatives and assisting small businesses and non-profits with data privacy compliance.